⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

May 10, 2024Transplant Infectious DiseaseOpen Access

Cytomegalovirus surveillance after antiviral prophylaxis in CMV mismatched transplant patients: Does recurrent cytomegalovirus DNAemia impact patient survival?

Oscar A. Fernández‐García Cristina Hernandez Mark L. Robbins Dima Kabbani Karen Doucette Carlos Cervera

View Full Paper

Ask AI

Bookmark

Share

Abstract

Cytomegalovirus (CMV) mismatched, donor IgG-positive/recipient IgG-negative, solid organ transplant recipients (SOTRs) are at high risk of CMV invasive disease. Post-prophylaxis disease is an issue in this population. Some programs employ surveillance after prophylaxis (SAP) to limit the incidence of post-prophylaxis disease.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Fernández‐García et al. (2024) studied this question.

synapsesocial.com/papers/68e6ab33b6db64358762da21 https://doi.org/10.1111/tid.14292

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Effect of CMV Mismatch on Heart Transplant Outcomes Using a Surveillance and Preemptive Strategy2024 · 2 citations
2Cytomegalovirus in transplantation – challenging the<i>status quo</i>Review · 2006 · 289 citations
3Determinants of protracted cytomegalovirus infection in solid-organ transplant patients1Original Research · 2002 · 32 citations
4Cytomegalovirus Post‐Prophylaxis Surveillance in High‐Risk Kidney and Liver Recipients Prevents CMV End‐Organ Disease and Ganciclovir‐Resistance2024 · 7 citations
5Refractory, Resistant and Recurrent Cytomegalovirus Infections in Solid Organ Transplant Recipients: Risk Factors and Clinical Outcomes.Cohort Study · 2026